Actionnariat et activité des initiés pour DBV Technologies S.A. (DBVT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $11.79 |
| Capitalisation | $282M |
| Bourse | NASDAQ |
| Pays | FR |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-29 | Mohideen Pharis | S-Sale | 464 | $1K |
| 2025-10-30 | Lee Philina | |||
| 2026-01-29 | Mohideen Pharis | S-Sale | 534 | $3K |
| 2026-01-12 | BAKER BROS. ADVISORS LP | M-Exempt | 25,005,240 | |
| 2026-01-12 | BAKER BROS. ADVISORS LP | M-Exempt | 2,299,656 | |
| 2026-01-12 | BAKER BROS. ADVISORS LP | M-Exempt | 25,005,240 | |
| 2025-12-17 | EPIC Bpifrance | S-Sale | 2,036,990 | $9.9M |
| 2025-12-17 | EPIC Bpifrance | S-Sale | 40,000 | $211K |
| 2025-12-18 | EPIC Bpifrance | S-Sale | 1,292,103 | $5.4M |
| 2025-11-21 | Mohideen Pharis | A-Award | 253,000 | $734K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $282.9M | $194.1M | $167.8M | $193.3M | $196.4M | $77.3M | $209.2M | $141.4M | $32.5M | $194.2M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $13.6M | $19.9M | $20.2M | $5.4M | $7.9M | $33.1M | $11.2M | $15.4M | $10.4M | $16.1M |
| Stocks | 0 | $2.9M | $2.1M | $2.3M | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $300.3M | $220.8M | $198.8M | $204.6M | $207.4M | $114.5M | $223.1M | $158.9M | $44.4M | $212.9M |
| Immobilisations Corporelles | $13.8M | $25.1M | $27.6M | $48.6M | $34.9M | $24.9M | $17.6M | $17.9M | $16.8M | $14.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $105904 | $173137 | $41006 | $48000 | $41000 | $22000 | $10000 | $58000 | $40000 | $22000 |
| Actifs Totaux | $317.2M | $250.3M | $234.8M | $271.7M | $272.2M | $146.3M | $246.5M | $183.0M | $65.7M | $233.7M |
| Dettes Fournisseurs | $15.1M | $23.8M | $39.0M | $24.0M | $20.3M | $11.4M | $14.5M | $23.3M | $22.0M | $40.9M |
| Dette à Court Terme | $813036 | $3.9M | $3.5M | $4.3M | $4.4M | $3.5M | $8.9M | $883000 | $846000 | $16.3M |
| Passifs Courants | $32.0M | $50.6M | $59.5M | $54.0M | $52.7M | $31.4M | $29.5M | $37.3M | $31.1M | $58.0M |
| Dette à Long Terme | $4.5M | $2.6M | $1.7M | $810000 | $543000 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $49.3M | $67.4M | $69.0M | $78.5M | $66.8M | $47.3M | $52.1M | $42.8M | $38.3M | $64.9M |
| Réserves | -$126.3M | -$207.9M | -$227.0M | -$799.0M | -$958.5M | -$98.1M | -$259.6M | -$238.9M | -$286.4M | -$393.1M |
| Capitaux Propres | $267.9M | $182.9M | $165.8M | $193.2M | $205.5M | $99.0M | $194.5M | $140.2M | $27.4M | $168.8M |
| Dette Totale | $5.3M | $6.5M | $5.2M | $27.1M | $15.5M | $10.7M | $10.0M | $6.6M | $7.8M | $21.7M |
| Dette Nette | -$277.7M | -$187.6M | -$162.6M | -$166.1M | -$180.9M | -$66.6M | -$199.2M | -$134.8M | -$24.7M | -$172.5M |
| Fonds de Roulement | $268.3M | $170.2M | $139.3M | $150.6M | $154.7M | $83.1M | $193.6M | $121.6M | $13.3M | $154.9M |
Santé financière
| Dette / Capitaux propres | 0.14 |
| Ratio de liquidité | 3.72 |
Rentabilité
| Rentabilité des capitaux propres | -119.47% |
| Rentabilité du capital investi | -97.30% |
| Rentabilité des actifs | -78.97% |
| Marge brute | -122.19% |
| Marge opérationnelle | -3166.43% |
| Marge nette | -3074.92% |
Entreprises liées: ALT · AMRN · ANNX · ANRO · CLLS · ENGN · KRRO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DBVT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions